HK67995A - Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine - Google Patents

Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine

Info

Publication number
HK67995A
HK67995A HK67995A HK67995A HK67995A HK 67995 A HK67995 A HK 67995A HK 67995 A HK67995 A HK 67995A HK 67995 A HK67995 A HK 67995A HK 67995 A HK67995 A HK 67995A
Authority
HK
Hong Kong
Prior art keywords
dideoxycytidine
htlv
iii
lav
inhibition
Prior art date
Application number
HK67995A
Other languages
English (en)
Inventor
Hiroaki Mitsuya
Samuel Broder
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of HK67995A publication Critical patent/HK67995A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK67995A 1985-08-26 1995-05-04 Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine HK67995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76901785A 1985-08-26 1985-08-26

Publications (1)

Publication Number Publication Date
HK67995A true HK67995A (en) 1995-05-12

Family

ID=25084170

Family Applications (1)

Application Number Title Priority Date Filing Date
HK67995A HK67995A (en) 1985-08-26 1995-05-04 Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine

Country Status (12)

Country Link
EP (1) EP0216511B1 (xx)
JP (1) JPS62501777A (xx)
AT (1) ATE96326T1 (xx)
AU (1) AU570855B2 (xx)
CA (1) CA1277915C (xx)
DE (1) DE3689221T2 (xx)
HK (1) HK67995A (xx)
IE (1) IE63001B1 (xx)
IL (1) IL79699A (xx)
NL (1) NL940019I2 (xx)
NZ (1) NZ217184A (xx)
WO (1) WO1987001283A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960001372B1 (ko) * 1986-09-24 1996-01-26 예일 유니버시티 레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
GB8712691D0 (en) * 1987-05-29 1987-07-01 Wellcome Found Therapeutic nucleosides
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
EP0294113A1 (en) * 1987-05-29 1988-12-07 The Wellcome Foundation Limited Therapeutic nucleosides
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
JPH03501253A (ja) * 1987-09-22 1991-03-22 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア エイズ（ａｉｄｓ）治療を目的とするリポソームによるヌクレオシド類似物質
AU5659990A (en) * 1989-05-15 1990-12-18 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method of treatment of hepatitis
US5071983A (en) * 1989-10-06 1991-12-10 Burroughs Wellcome Co. Therapeutic nucleosides
US5192749A (en) * 1990-05-21 1993-03-09 Syntex (U.S.A.) Inc. 4'-substituted nucleosides
CA2270600A1 (en) 1999-05-03 2000-11-03 Infectio Recherche Inc. Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK224286A (da) * 1985-05-15 1986-11-16 Wellcome Found 2',3'-dideoxy-nucleosider

Also Published As

Publication number Publication date
NL940019I1 (nl) 1994-12-01
IE862264L (en) 1987-02-26
IL79699A (en) 1992-07-15
AU6284386A (en) 1987-03-24
NL940019I2 (nl) 1997-07-01
EP0216511A2 (en) 1987-04-01
ATE96326T1 (de) 1993-11-15
EP0216511A3 (en) 1989-08-02
NZ217184A (en) 1990-03-27
CA1277915C (en) 1990-12-18
EP0216511B1 (en) 1993-10-27
JPS62501777A (ja) 1987-07-16
WO1987001283A1 (en) 1987-03-12
IL79699A0 (en) 1986-11-30
IE63001B1 (en) 1995-03-08
JPH0215524B2 (xx) 1990-04-12
DE3689221D1 (de) 1993-12-02
AU570855B2 (en) 1988-03-24
DE3689221T2 (de) 1994-02-24

Similar Documents

Publication Publication Date Title
AU6196886A (en) Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
GR3003631T3 (xx)
HK67995A (en) Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine
NO813265L (no) Fremgangsmaate for konsentrering av en polysakkaridloesning, samt anvendelse av den konsentrerte loesning
ES514643A0 (es) "procedimiento de preparar nuevos derivados as-triacinicos condensados".
GR861132B (en) (1,4) benzodioxin and (1,4) benzoxazine derivatives
TR23271A (tr) En asagi % 95.5 safliginda p-ksilol'un kazanilmasina mahsus usul
MA20491A1 (fr) Procede de preparation d'aminomethylene-2 indanedione-1,3 substituees sur l'azote
Koutsouki Koskina The effect of instruction on tracking performance at two levels of skill: a knowledge based approach
Takashima On the Theory of Poroductive Powers
IT8220398A0 (it) Procedimento ed apparecchiatura per correggere le asimmetricita' di centratura di una ruota a raggi in senso parallelo all'asse della ruota.
IT8305134A0 (it) Impianto per l'essiccamento della tornitura con recupero di calore.
EP0173480A3 (en) The antiviral use of phyllanthostatins
ES265220Y (es) "valvula de paso directo, perfeccionada".
ES263933Y (es) "colector solar simple por chorreo".
ES263418Y (es) "diferencial perfeccionado".
ES267938Y (es) "cuaderno de notas perfeccionado".
ES285369Y (es) Sonajero infantil,perfeccionado
FI853465A0 (fi) Rotationsanordning foer anordning av roerelsebanan av fogplanet av en cylindermantel med vikbar axel i ett lodraett plan.
IE851446L (en) Epimerization at c6 of 3,4,5,6-tetrahydro-2h-pyran-2-one
ES263658Y (es) "mesa perfeccionada".
IT8025582A0 (it) Circuito per l'eliminazione dei disturbi.
SG32294G (en) Inhibition of in vitro infecivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine
ES264438Y (es) "muneco andador estatico perfeccionado".
RO90889A2 (ro) Procedeu de obtinere a unor stratificate cu stabilitate termica ridicata

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20060820